Why the study?
Is long-term use of low-molecular-weight heparin (enoxaparin) safe and effective for anticoagulation in hemodialysis patients?
Population
236 hemodialysis patients
Comparison
Low-molecular-weight heparin during hemodialysis vs Unfractionated heparin
Design
Cohort
Follow-up
7 years
Authors
Loading...
May allow reduced-dose enoxaparin in long-term HD without adverse platelet or lipid effects; extends observational data but leaves open RCT confirmation.
Is long-term use of low-molecular-weight heparin (enoxaparin) safe and effective for anticoagulation in hemodialysis patients?
Long-term use of low-molecular-weight heparin (enoxaparin) at a reduced dose is practical and safe for hemodialysis patients.
Bernieh et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: